Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://endpts.com/statera-biopharma-gets-the-ok-to-resume-the-study-of-a-potential-stockpile-drug-for-lethal-radiation-exposure/
https://www.contractpharma.com/contents/view_breaking-news/2021-08-31/cytocom-to-become-statera-biopharma/?widget=listSection
https://www.contractpharma.com/contents/view_breaking-news/2021-08-31/cytocom-to-become-statera-biopharma/?widget=listSection
https://www.prnewswire.com/news-releases/cytocom-inc-reports-second-quarter-2021-financial-results-301355490.html
https://www.contractpharma.com/contents/view_breaking-news/2021-08-13/cytocom-to-fund-research-and-lab-facilities-at-the-la-jolla-institute-for-immunology/?widget=listSection
https://www.prnewswire.com/news-releases/cytocom-inc-and-la-jolla-institute-for-immunology-announce-five-year-research-alliance-agreement-301354636.html
https://www.prnewswire.com/news-releases/cytocom-inc-provides-update-on-completed-merger-with-cleveland-biolabs-301349236.html
https://www.biospace.com/article/releases/cleveland-biolabs-inc-and-cytocom-announce-registration-statement-and-proxy-statement-for-previously-announced-merger-declared-effective-by-sec/?s=79
https://www.contractpharma.com/contents/view_breaking-news/2021-03-16/cytocom-gets-fda-clearance-for-phase-ii-trial-of-covid-immune-therapy/?widget=listSection